Rice Hall James & Associates’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Sell
17,905
-63
-0.4% -$5.16K 0.07% 190
2025
Q4
$1.4M Sell
17,968
-3,916
-18% -$318K 0.08% 181
2025
Q3
$1.86M Sell
21,884
-10,187
-32% -$816K 0.1% 166
2025
Q2
$2.51M Sell
32,071
-2,691
-8% -$198K 0.14% 143
2025
Q1
$2.52M Sell
34,762
-187
-0.5% -$15.7K 0.15% 140
2024
Q4
$3.1M Buy
34,949
+8,831
+34% +$787K 0.17% 136
2024
Q3
$2.21M Sell
26,118
-198
-0.8% -$17.6K 0.12% 167
2024
Q2
$2.43M Sell
26,316
-1,693
-6% -$171K 0.15% 144
2024
Q1
$3.16M Sell
28,009
-93
-0.3% -$9.29K 0.18% 120
2023
Q4
$2.62M Sell
28,102
-1,219
-4% -$107K 0.15% 142
2023
Q3
$2.69M Sell
29,321
-152
-0.5% -$16.3K 0.17% 135
2023
Q2
$3.58M Sell
29,473
-3,795
-11% -$409K 0.2% 116
2023
Q1
$3.26M Sell
33,268
-515
-2% -$49.1K 0.19% 134
2022
Q4
$2.74M Buy
33,783
+7,570
+29% +$635K 0.16% 153
2022
Q3
$1.99M Buy
26,213
+520
+2% +$50K 0.12% 188
2022
Q2
$2.81M Buy
25,693
+182
+0.7% +$19.3K 0.14% 152
2022
Q1
$2.54M Buy
25,511
+100
+0.4% +$9.54K 0.1% 189
2021
Q4
$2.43M Buy
25,411
+7,900
+45% +$792K 0.09% 197
2021
Q3
$1.94M Buy
17,511
+13
+0.1% +$1.48K 0.07% 211
2021
Q2
$2.03M Sell
17,498
-539
-3% -$61.9K 0.07% 215
2021
Q1
$1.88M Sell
18,037
-132
-0.7% -$16.4K 0.06% 223
2020
Q4
$2.19M Sell
18,169
-760
-4% -$76.7K 0.08% 178
2020
Q3
$1.65M Buy
18,929
+1,686
+10% +$145K 0.07% 190
2020
Q2
$1.4M Buy
+17,243
New +$1.26M 0.06% 183
2019
Q1
Sell
-13,389
Closed -$1.37M 306
2018
Q4
$1.37M Buy
13,389
+1,396
+12% +$155K 0.05% 227
2018
Q3
$1.42M Sell
11,993
-8,740
-42% -$987K 0.05% 231
2018
Q2
$1.99M Sell
20,733
-12,227
-37% -$1.13M 0.07% 204
2018
Q1
$2.68M Sell
32,960
-7,443
-18% -$577K 0.1% 141
2017
Q4
$2.92M Sell
40,403
-2,110
-5% -$144K 0.11% 136
2017
Q3
$2.61M Sell
42,513
-135
-0.3% -$8.22K 0.12% 152
2017
Q2
$2.58M Sell
42,648
-2,398
-5% -$153K 0.11% 144
2017
Q1
$2.94M Sell
45,046
-1,200
-3% -$85.1K 0.14% 118
2016
Q4
$3.25M Sell
46,246
-400
-0.9% -$25.4K 0.16% 116
2016
Q3
$2.92M Sell
46,646
-200
-0.4% -$12.3K 0.15% 121
2016
Q2
$2.82M Sell
46,846
-1,127
-2% -$61.8K 0.16% 113
2016
Q1
$2.39M Buy
47,973
+100
+0.2% +$4.97K 0.14% 139
2015
Q4
$2.57M Sell
47,873
-23,417
-33% -$1.17M 0.15% 133
2015
Q3
$3.2M Buy
71,290
+1,200
+2% +$59.8K 0.21% 108
2015
Q2
$3.84M Sell
70,090
-570
-0.8% -$28.2K 0.22% 102
2015
Q1
$3.36M Sell
70,660
-16,404
-19% -$697K 0.19% 127
2014
Q4
$3.65M Sell
87,064
-478
-0.5% -$18.8K 0.22% 112
2014
Q3
$3.1M Sell
87,542
-1,550
-2% -$54.8K 0.22% 113
2014
Q2
$3.05M Sell
89,092
-590
-0.7% -$19K 0.2% 120
2014
Q1
$3.1M Sell
89,682
-2,919
-3% -$96.9K 0.23% 116
2013
Q4
$3.27M Sell
92,601
-4,450
-5% -$146K 0.24% 113
2013
Q3
$3.02M Buy
97,051
+600
+0.6% +$17.7K 0.29% 108
2013
Q2
$2.67M Buy
+96,451
New +$2.55M 0.26% 108

Other funds holding USPH

Rice Hall James & Associates's USPH Position: Q1 2026 in Review

Rice Hall James & Associates reduced its US Physical Therapy (USPH) stake by 0.35% in Q1 2026, selling an estimated $5.16K and leaving 17,905 shares worth $1.34M. The position accounts for 0.07% of the portfolio, ranked #190.

Rice Hall James & Associates first reported a position in USPH in Q2 2013 and has held it in 47 quarters since. The position peaked at $3.84M in Q2 2015. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Rice Hall James & Associates held 17,905 shares of US Physical Therapy worth $1.34M as of Q1 2026.
  • Rice Hall James & Associates sold 63 US Physical Therapy shares in Q1 2026, an estimated $5.16K.
  • US Physical Therapy made up 0.07% of Rice Hall James & Associates's portfolio in Q1 2026, its #190 holding.
  • Rice Hall James & Associates first reported a position in US Physical Therapy in Q2 2013 and has held it in 47 quarters since.
  • Rice Hall James & Associates's US Physical Therapy position peaked at $3.84M in Q2 2015.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.